Clinical Trials Browser

Interventional × Osteosarcoma × eribulin × Clear all

NCT02097238 2020-05-19

Eribulin Mesylate in Treating Patients With Recurrent or Refractory Osteosarcoma

Phase 2 Completed

19 enrolled 12 charts

Osteosarcoma